adjust estim proair
adjust estim reflect delay launch gener
proair due expect note may follow prgo
announc see gener proair take breather anoth may
prgo inabl win approv gener version proair clearli setback
effect ignor manag previous guid
expect contribut adjust ep longer expect
earn contribut obvious substanti
model revenu possibl depend natur
could retain much approv obtain earli though
conserv model launch modest revenu
lupin file anda march case dismiss could
result settlement think that unlik sinc neither parti disclos
agreement base compani commentari believ cipla cover pursu
proair along hfa product dont believ theyv submit
anda yet assum delay protract suspect retain first-
manag provid detail reason behind
belief expect timelin remedi fda concern expect
detail compani follow receipt requir
minor amend compani applic get review fda
sinc proair prioriti applic first-tim gener major amend would
undergo month review depend whether pre-approv inspect
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight expect show
improv result core chc busi
move past recent headwind leverag
upcom product launch drive growth
particular highlight expect launch
store-brand nasacort flonas mucinex also
believ investor attract perrigo
see upsid acceler demand store-
brand product base macro econom condit
opportun capit deploy
risk includ inabl launch new product
on-tim unfavor season trend would
result lower sale drive multipl
dougla tsao herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
